Amgen Inc. (AMGN) Q1 2016 Earnings Results

Amgen Beats on EPS, Stock Down 0.27%

Amgen reported better-than-expected earnings per share, which indicates strong operational performance. However, the stock fell slightly by 0.27%, likely due to the lack of revenue details and guidance. Investors may be cautious as they await more comprehensive insights into future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.90	N/A	+13.33%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed confidence in the company's product pipeline and future growth. They noted the importance of innovation in maintaining competitive advantage.

Management highlighted strong performance in key product areas.

They emphasized ongoing investment in research and development.

The company remains focused on long-term growth despite current market challenges.

Amgen Beats on EPS, Stock Down 0.27%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Down 0.27%

Key numbers

Management commentary